Human Albumin and Anti D
Estimated value
£11k
Awarded value
£11k
Awarded 01 Mar 2021
Suppliers
1
Lots
1
1 awarded
Published
03 Mar 2021
Deadline 28 Feb 2021
Description
Alburex Human Albumin 20% contract
Scope
- Reference
- WHPC00031
- Total value
- £11,100 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 01 Mar 2021 to 29 Apr 2022
- CPV classifications
- 85000000
Submission & procedure
- Submission deadline
- 28 Feb 2021, 12:00 pm
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£11k
Award date
01 Mar 2021
Contract start
01 Mar 2021
Contract end
29 Apr 2022
Awarded to
Awarded suppliers· 1 supplier
Awarded 01 Mar 2021 · Contract period 01 Mar 2021 — 29 Apr 2022
Award value
£11k
Other contracts from Walsall Healthcare NHS Trust
Full notice and award history for this contracting authority is on the buyer profile.
Other contracts awarded to CSL BEHRING UK LIMITED· 10
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| Beriplex | contract | £12k | 15 Jul 2026 |
| Medicinal Products and Pharma Funded Homecare [5749446] | contract | — | 17 Jun 2025 |
| NP48925b Hereditary Angioedema Branded Medicines (Berinert) | contract | — | 02 May 2025 |
| NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 1 May 2025 | contract | — | 22 Apr 2025 |
| NP48925b Hereditary Angioedema Branded Medicines (Berinert) | contract | — | 04 Apr 2025 |
| CSL Behring - Blood Disorder Treatment products (inc Haemophilia A & B) | contract | £416k | 12 Mar 2025 |
| NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin | contract | — | 20 Jan 2025 |
| NHS Framework Agreement for the supply of Human Immunoglobulin and Anti-D Immunoglobulin | contract | — | 29 Nov 2024 |
| Human Derived Blood Products | contract | — | 28 Aug 2024 |
| NHS Framework - Blood Disorders including Haemophilia A and B - July 2024 | contract | — | 11 Jun 2024 |